Tag Archives: surgical site infections

Jun 28, 2018

3M Science at APIC 2018

Posted by:

3M Science at APIC 2018The biggest infection prevention conference of the year, the 45th APIC Annual Conference, was held last week right in 3M’s backyard of Minneapolis, Minnesota. We were excited to be part of the movement to advance the infection prevention efforts of facilities across the country and to help clinicians move toward reducing rates of preventable infections.

Breakfast Symposium: Reducing the Risks of CLABSI and SSI

On Friday morning, 160 APIC attendees gathered for a symposium on “Reducing the Risks of CLABSI and SSI: What Is the Evidence?” Mark Rupp, M.D., professor and chief of the division of Infectious Diseases and director of Infection Control & Epidemiology at the University of Nebraska Medical Center, shared his expertise on evidence-based measures to prevent CLABSI/CRBSI. Peggy Prinz Luebbert, MS, CLS, CIC, CHSP, CSPDT, addressed interventions in preparing patients for surgery that help reduce the risk of SSI.

IP Survey: Human Factors and the Future of Infection Prevention

3M also highlighted the results from a survey of clinicians and infection preventionists (IPs), “Human Factors and the Future of Infection Prevention,” which uncovered the key challenges they face in their fight to reduce infections in their facilities.

The survey uncovered barriers that impact successful infection prevention, including a lack of adopting new technology and processes (51%), lack of senior leadership support (51%) and poor protocol compliance (50%). However, many IPs (45%) agree that their facility could prevent more infections with more high-quality data and tools. One-third of clinicians believe infections can be avoided entirely when providing care to patients.

We want to continue this conversation and find more ways to support clinicians in their fight against healthcare associated infections. Please join us July 11 for the first in a series of webinars to discuss the IP survey results.

Both the symposium and survey results emphasized the importance of preventing infections using a three-pronged approach: developing highly trained and committed people, incorporating industry standards and implementing evidence-based technology and we were excited to showcase some of our newest offerings that help clinicians in the fight to zero infections.

If you didn’t make it to the 3M booth at APIC 2018, here are some of the new product highlights:

3M™ Tegaderm™ Antimicrobial IV Advanced Securement Dressing

To better combat bloodstream infections, specifically peripheral line associated bloodstream infections (PLABSI), we introduced a new dressing to expand the 3M antimicrobial product offerings. The new dressing integrates 2% chlorhexidine gluconate (CHG) throughout the adhesive to suppress skin flora regrowth on prepped skin for up to 7 days, which can offer another line of defense against contamination. It also provides site visibility, catheter securement and is designed for consistent application. A non-bordered version of the dressing called Tegaderm Antimicrobial Transparent Dressing will also be available.

3M™ Skin and Nasal Antiseptic

Studies show that  approximately 30 percent of the population are colonized with Staphylococcus aureus (S. aureus), the leading cause of surgical site infections (SSIs). And, more than 80 percent of surgical site infections from S. aureus come from the patient’s own nasal flora. To combat this issue, 3M’s Skin and Nasal Antiseptic provides clinicians a simple, one-time application that reduces nasal bacteria, including S. aureus and MRSA, by 99.5 percent in just one hour and maintains this reduction for at least 12 hours. 3M’s nasal antiseptic is the only one supported by more than ten investigator-initiated clinical studies showing a reduction to the risk of SSIs.

3M™ Single-Patient Stethoscope

Leading healthcare organizations recommend using a single-patient stethoscope in isolation care settings, but the single-use stethoscopes on the market often fall short in terms of durability, sound quality and comfort. The new 3M stethoscope helps reduce the risk of cross-contamination  in isolation environments by providing clinicians a high-quality, disposable stethoscope that combines excellent sound quality and comfort to help eliminate the need to use personal stethoscopes.

3M™ Bair Hugger™ Temperature Monitoring System

Core body temperature is a vital indicator of health or illness of the acute care patient. For surgical patients, a small drop in core body temperature drop can result in unintended hypothermia (a temperature below 36.0°C), which can contribute to a number ofpreventable surgical complications. The 3M Bair Hugger™ Temperature Monitoring System is a non-invasive, consistent and easy-to-use system that accurately and continuously measures the patient’s core body temperature throughout the entire perioperative journey,  helpingclinicians proactively own the normothermic temperature zone and improve patient outcomes.

3M™ Attest™ Super Rapid Biological Indicator (BI) System for Steam and 3M™ Attest™ Auto-reader 490 and 490H units

Sterile processing professionals work to clean, disinfect, and sterilize all of the instruments that allow the perioperative staff to enter surgery prepared with the tools of their trade. 3M offers sterilization assurance solutions and expertise so the sterile processing department and your OR staff know surgical instruments are safe for patient use. Our new Attest™ Dual Auto-reader technology allows facilities to incubate both steam and Hydrogen peroxide BIs in the same auto-reader with fast 24-minute results – and is available via a free software upgrade to qualified hardware. Simplify, standardize and streamline Sterile Processing Department workflows with 3M innovation and expertise.

Jun 12, 2018

New survey finds infection preventionists want updated technology and processes to help fight HAI

Posted by:

Human Factors and the Future of Infection Prevention InfographicA recent survey of infection preventionists found that half (51 percent) believe lack of adopting new technology and processes and insufficient support from senior leadership are the top barriers to preventing healthcare-associated infections (HAI), followed closely by poor protocol compliance rates.

Despite the barriers, clinicians surveyed were optimistic about their ability to improve infection rates. One-third believed infections can be avoided when providing healthcare. Survey data also indicated these clinicians are seeking technological advances that will help them reduce preventable infections.

The survey, Human Factors and the Future of Infection Prevention, was commissioned by 3M and conducted by a third-party research firm in April 2018. Of the 650 completed interviews, 237 respondents identified themselves as infection preventionists. The remaining respondents were predominately nurses with patient care responsibilities.

“At 3M, we are on a mission to partner with clinicians to take on preventable infections,” Pat Parks, MD, PhD, Medical Director, 3M Medical Solutions Division stated in a press release issued earlier this week. “We wanted to gain a better understanding of beliefs and perceptions clinicians hold about the current reality and future potential of infection prevention. Armed with these insights, we’re convening with critical stakeholders to support clinicians in their fight against HAIs.”

Based on the survey data, 3M will be hosting a series of events focused on advancing infection prevention, starting with a webinar on July 11, 2018, to discuss in more depth the barriers to infection prevention revealed in the survey. Register at 3M.com/IPSurveyWebinar.

Upcoming events will reveal survey findings on clinicians’ attitudes and beliefs about infection prevention trends, best practices, compliance, auditing, and training.

Stay tuned for the full survey results – including insights on fighting both peripheral (PLABSI) and central line-associated bloodstream infections (CLABSI) and surgical site infections (SSI) – to be published later this year.

Jun 23, 2017

8 Reasons the 3M™ Bair Hugger™ System is the Gold Standard in Patient Warming

Posted by:
The 3M Bair Hugger System is the gold standard for patient warming. See the research in our updated Compendium.

The 3M Bair Hugger System is the gold standard for patient warming. See the research in our updated Compendium.

The 3M™ Bair Hugger™ forced-air warming system keeps patients warm throughout the perioperative process, which is integral to optimal clinical care and patient comfort. Below are eight great reasons you can trust the Bair Hugger system for your patient warming needs.

  1. Over 80% of US hospitals rely on the 3M Bair Hugger system to maintain normothermia.
  2. The 3M Bair Hugger system has safely and effectively warmed patients during surgery for nearly 30 years.
  3. More than 200 million patients have been warmed by Bair Hugger warming blankets or warming gowns.
  4. The number of patients warmed using the Bair Hugger system increases by nearly 50,000 each and every day.
  5. 8 of the top 10 orthopedic hospitals in the U.S. trust the 3M Bair Hugger system for their patient warming needs.¹
  6. The clinical effectiveness of forced-air warming has been documented in over 170 clinical studies and more than 60 randomized controlled clinical trials. Download the Bair Hugger research compendium to learn more.
  7. The 3M Bair Hugger system’s portfolio of 25 blanket designs (including seven underbody models) and three gown styles provides a warming option for nearly any surgical procedure.
  8. The 3M Bair Hugger Model 775 temperature management unit’s performance, precision and ease-of-use stands out from the competition.

Learn more about the 3M Bair Hugger system, or download the Bair Hugger Research Compendium.

1. U.S. News & World Report (online edition); 2015-16 Top Hospitals edition, Best Hospitals for Adult Orthopedics. http://health.usnews.com/best-hospitals/rankings/orthopedics. Published July 21, 2015.
Aug 2, 2016

3M™ Skin and Nasal Antiseptic effectively reduces S. aureus in the nares.

Posted by:
S. aureus, nasal decolonization

Photo credit: Centers for Disease Control and Prevention

How can you, as a health care provider select an effective skin antiseptic product?

How can you help reduce the risk of surgical site infection for each of your patients?

And how can you do all this in a cost-effective way?

We know that surgical skin prepping is a critical step in reducing the risk of surgical site infection – but it may not be enough. There is rising concern that surgical site infections can be caused by bacteria in the nares of surgical patients and colonization with Staphylococcus aureus (S. aureus) is a well-documented risk factor. By reducing S. aureus in the nares before surgery, we can help reduce the risk of surgical site infection and other complications.

This is why we at 3M have developed an innovative product to reduce bacteria in the nares – 3M™ Skin and Nasal Antiseptic, (Povidone-Iodine Solution 5% w/w [0.5 available iodine] USP) Patient Preoperative Skin Preparation. Our product contains a 5% povidone-iodine solution that was specially formulated for use in the nose. A simple one-time application prior to surgery is sufficient to effectively reduce bacteria in your patients’ nares.

Here is what I think you may ask: “Why not just use a standard 10% povidone-iodine solution? It would be inexpensive and it even contains double the amount of iodine.” Good question, but in this case, more is not always better!

Even though off-the-shelf 10% povidone-iodine solution has been used for decades as an effective surgical skin prep, it may not be the product you should consider as a first choice for prepping of the nares. The unique environment of the nose with its constant build-up of mucus tends to wash out a standard povidone-iodine solution. This may make it difficult for you to achieve an effective and long-lasting reduction of bacteria in the nares of your patients.

The special formulation of 3M™ Skin and Nasal Antiseptic combines 5% povidone-iodine with a film-forming polymer that helps povidone-iodine adhere to the inner lining of the nose and, you guessed it, prevents it from being flushed out. The solution is also formulated to be pH-balanced. This makes it is less irritating and improves your patients’ comfort and acceptability.

But how can you be assured that our product works in the clinical setting; that our nasal antiseptic swabs are more effective than standard povidone-iodine?

A prospective randomized controlled clinical trial in 429 total joint arthroplasty patients was conducted to answer this question (Rezapoor et al., 2015). The patients were randomized into 1 of 3 groups, each receiving a different treatment to evaluate its efficacy in reducing S. aureus in the nares:

1) Off-the-shelf 10% povidone-iodine solution

2) 3M™ Skin and Nasal Antiseptic

3) Saline solution (control)

Baseline cultures were obtained and the nares were swabbed for culture again at 4 and 24 hours after treatment to determine the remaining S. aureus.

Our 5% povidone-iodine vs. 10% povidone-iodine study achieved the results we had expected – 3M™ Skin and Nasal Antiseptic was significantly more effective (p=0.003) at reducing S. aureus in the nares over the 4 hour time interval than standard 10% povidone-iodine solution. Standard povidone-iodine was similar in efficacy to the saline control.

The study results are visualized in the graph below.

Negative Nasal S. Aureus Cultures Post Treatment

These results at 4 hours demonstrate that 3M™ Skin and Nasal Antiseptic reduces S. aureus significantly better than standard 10% povidone-iodine solution to provide the assurance you need that by choosing 3M™ Skin and Nasal Antiseptic, you use the best products for your patients.

Here are some additional benefits of the 3M™ Skin and Nasal Antiseptic you may want to consider when selecting an antiseptic for the nares:

  • The broad-spectrum, fast-acting povidone-iodine antiseptic fits easily into your preoperative process
  • The film-forming formula was designed to work within one hour and maintain at least 12 hours of persistence (3M Study 05-011100)
  • It is effective against antibiotic resistant strains of S. aureus (in vitro*) (3M Study 05-010944)
  • No resistance has been shown (in vitro*) (3M Study 05-011322)
  • Compliance is not an issue because you as the caregiver apply the solution to the patient’s nares
  • The one-time application an hour before surgery makes the procedure very quick and easy
  • Surgical site infections are associated with increased health care cost, so using an effective product to reduce nasal carriage of bacteria may be a cost-effective addition to your preoperative protocol

So, in summary, the 3M™ Skin and Nasal Antiseptic is the only 5% povidone-iodine product that has been shown in a clinical study to be significantly more effective in reducing S. aureus in the nares than standard 10% povidone-iodine. Due to the adherent polymer, the 5% povidone-iodine remains in the nares for a longer period, which explains the better efficacy of this product. This confirms what I had mentioned in the beginning – that more is not always better.

As you can see, by choosing the 3M™ Skin and Nasal Antiseptic as part of a comprehensive preoperative protocol, you can help to safely and effectively reduce the risk of surgical site infections in your patients – and all in a budget-conscious manner!

References:

Rezapoor M, Nicholson T, Patel R, et al. Do iodine-based solutions differ in their effectiveness for decolonizing intranasal Staphylococcus aureus? Presented at the MSIS Annual Meeting, Cleveland, OH, August 2015.

3M Study 05-011100

3M Study 05-010944

3M Study 05-011322

*The clinical significance of in vitro data is unknown

Jul 25, 2016

Researchers add to wealth of evidence supporting 3M™ Bair Hugger™ patient safety

Posted by:

The 3M™ Bair Hugger™ patient warming system has warmed more than 200 million patients since its launch in 1987, and that number grows by nearly 50,000 patients each day. One reason for the Bair Hugger system’s success is an impressive history of safety and effectiveness.

So when a competitor makes outlandish claims that fly in the face of 28 years of clinical use and a wealth of scientific research (over 170 studies and more than 60 randomized controlled clinical trials document the clinical benefits, efficacy and safety of forced-air warming), we will rely on science to set the record straight.

Researchers John P. Abraham, Ph.D., Professor of Thermal Sciences at the University of St. Thomas, and Jennifer A. Wagner, Ph.D., Prism Environmental Health and Safety Solutions, recently released the results of a study, which found that the Bair Hugger system did not disrupt clean operating room airflow and did not move air from the the floor to the surgical site.  The Bair Hugger Warming System is a safe, effective method to warm your surgical patients. Take a few minutes to review the study overview below. The videos also do an excellent job of depicting the results, and can be viewed here.

Operation Room Air Flow Study with 3M™ Bair Hugger™ Warming System in Simulated Hip Replacement Surgery

John P. Abraham, Ph. D., University of St. Thomas and Jennifer A. Wagner, Ph. D., Prism Environmental Health and Safety Solutions

The Bair Hugger Warming System provides a safe and effective way to maintain normal body temperature during surgery.  When used properly the Bair Hugger Warming System lowers the risk of hypothermia and improves patient recovery and surgery outcomes (i.e. reduces risk of surgical site infection, blood loss and transfusion requirement, prolonged recovery, and fatal heart attack).  A scientific research project was undertaken to assess whether the Bair Hugger System disturbed the clean-air flow in an operating room in the vicinity of a sterile surgical site.  The investigation showed that the Bair Hugger Warming System did not disrupt the normal airflow patterns of an operating room, and did not move air from the floor to the surgical site in a simulated hip replacement procedure.

The investigation had three separate components. One part of the investigation incorporated advanced mathematical calculations based upon the fundamental laws of physics to track the paths of airflow in the operating room. The calculations demonstrated that the air from the Bair Hugger System avoided the surgical site. The air flow that emerged from the Bair Hugger System traveled away from the surgical table and migrated toward the room exhaust vents along with the air beneath the operating table – not toward the surgical site.

A second part of the investigation involved experiments performed in an operating room with flow visualization studies that purposely injected visible fog into multiple locations in the room: 1) behind the anesthesia screen where the Bair Hugger air would exit near the patient’s head; 2) underneath the surgical table; and 3) next to the surgical table, near the surgical team, and near the surgical site. This investigation found that downward clean moving air from ceiling supply ducts in an operating room inhibited air from other sources from intruding into the surgical region. The downward flow of clean air worked irrespective of whether the Bair Hugger Warming System was used or not.

The third part of the investigation included a review of the scientific literature. The best scientific work did not show any causal link between the use of a Bair Hugger Warming System and surgical site infections. Even contrary research, which was largely funded by a competitive company, failed to show any causal link. More than 170 clinical studies have utilized the Bair Hugger system, and studies have demonstrated forced-air warming’s clinical effectiveness. Studies have demonstrated perioperative temperature management with forced-air warming actually reduces the risk of surgical site infections, surgical bleeding3-5 and risk of heart attack6.

The findings of the three components of this investigation mutually reinforce one another. All of these studies showed that the Bair Hugger Warming System is safe when used according to manufacturer directions, providing an effective way to maintain patient temperature.

References:

1. Kurz, A. Sessler, DI. Lenhardt, R. Perioperative Normothermia to Reduce the Incidence of Surgical Wound Infection and Shorten Hospitalization. N Engl J Med. 1996;334:1209-15.

 2. Mahoney, CB. Odom, J. Maintaining intraoperative normothermia: A meta-analysis of outcomes with costs. AANA Journal. 1999;67(2):155-164.

 3. Rajagopalan, S. Mascha, E. Na, J. et. al. The Effects of Mild Perioperative Hypothermia on Blood Loss and Transfusion Requirement. Anesthesiology. Jan 2008;108(1):71-77.

 4. Schmeid H, Kurz A, Sessler DI, Kozek S, Reiter A. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996:347(8997):289–92.

 5. Winkler M, Akça O, Birkenberg B, et al. Aggressive warming reduces blood loss during hip arthroplasty. Anesth Analg 2000;91(4):978–84.

 6. Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events: a randomized clinical trial. JAMA 1997;277:1127–34.